Dextran + Dextrose

Introduction

Dextran and Dextrose is a combination of two agents used primarily in intravenous (IV) therapy for the treatment of hypovolemia (low blood volume), shock, and dehydration. Dextran is a high-molecular-weight polysaccharide used as a plasma expander, while Dextrose is a form of glucose that provides energy and restores blood sugar levels. Together, they are used to treat patients with low blood volume and low blood sugar, often in emergency or perioperative settings.

Uses

The combination of Dextran and Dextrose is used to:

• Expand blood plasma volume in cases of hypovolemia or shock.
• Provide energy and raise blood glucose levels in cases of hypoglycemia or dehydration.
• Support patients undergoing surgery, trauma, burns, or other conditions that result in significant fluid loss.
• Serve as part of the maintenance fluid therapy in patients requiring IV nutrition or hydration support.

Mechanism of Action

Dextran works as a plasma volume expander by drawing water from the surrounding tissues into the bloodstream, thus increasing blood volume and improving circulation. Dextrose, on the other hand, provides a source of glucose, which is rapidly metabolized by the body's cells to produce energy. The combination helps in replenishing lost fluids, stabilizing blood sugar, and improving hemodynamic status.

How Long Does It Take to Work?

The effects of Dextran and Dextrose can be seen relatively quickly after intravenous administration, with an increase in plasma volume and blood glucose levels typically observed within minutes to an hour of infusion. The duration of effect depends on the clinical situation, the dose administered, and the patient's overall health.

Absorption

Dextran and Dextrose are both administered intravenously, bypassing the need for gastrointestinal absorption. Dextrose is rapidly taken up by the cells and utilized for energy, while Dextran remains in the bloodstream for a longer duration, exerting its plasma-expanding effects.

Route of Elimination

Dextran is primarily eliminated via the kidneys, with smaller molecules being excreted in the urine. Larger Dextran molecules are broken down in the liver before renal excretion. Dextrose is metabolized by the body's cells into water and carbon dioxide, with excess glucose being stored as glycogen in the liver or converted to fat for longer-term storage.

Dosage

• As dextran 40 (10% soln): Initial: 500 ml on day 1, followed by 500 ml on day 2 and subsequently on alternate days up to 10 days. Prophylaxis of post-op thromboembolic disorders. 500 ml during or at the end of surgery. May repeat dose next day and continue treatment on alternate days for up to 10 days in high-risk patients.

The dosage of Dextran and Dextrose varies based on the specific clinical condition being treated:

• For Plasma Expansion: A typical dose for plasma expansion with Dextran 40 or Dextran 70 is 500-1000 mL IV, given as needed to maintain adequate blood volume. The infusion rate may be adjusted depending on the patient's condition.
• For Dextrose Supplementation: Dextrose concentration in IV solutions varies from 5% (D5W) to higher concentrations, such as 10% or 50%, depending on the degree of hypoglycemia or energy requirement. The dose may range from 100-500 mL depending on blood glucose levels and patient needs.

Administration

Dextran and Dextrose are administered intravenously, typically in a hospital setting under medical supervision. The infusion rate is adjusted based on the patient's clinical status, with close monitoring of vital signs, urine output, and blood glucose levels.

Side Effects

Common side effects include:

• Nausea or vomiting
• Headache
• Fluid overload, which can lead to edema
• Electrolyte imbalances (particularly hyperglycemia)
• Allergic reactions, particularly to Dextran, which may cause anaphylaxis in rare cases
• Potential bleeding disorders due to Dextran's antithrombotic properties

Toxicity

Toxicity related to Dextran can include circulatory overload, hypervolemia, and rare instances of kidney damage or anaphylactic shock. High doses of Dextrose can lead to hyperglycemia, metabolic acidosis, and osmotic diuresis. Treatment for toxicity focuses on discontinuation of the infusion and supportive measures, including fluid management and correction of any metabolic disturbances.

Precautions

Precautions should be taken when using Dextran and Dextrose in patients with pre-existing conditions such as:

• Renal or hepatic impairment
• Heart failure or other conditions prone to fluid overload
• Diabetes, as Dextrose can significantly raise blood glucose levels
• Coagulation disorders or bleeding risks, as Dextran may inhibit platelet function

Interaction

Dextran and Dextrose may interact with the following:

• Anticoagulants: Dextran may potentiate the effects of blood thinners such as heparin or warfarin, increasing the risk of bleeding.
• Insulin: High doses of Dextrose can interfere with insulin therapy, requiring adjustments in insulin dosing.
• Diuretics: Concomitant use with diuretics may lead to electrolyte imbalances or dehydration.

Disease Interaction

Caution is advised in patients with heart failure, kidney disease, liver disease, or diabetes, as these conditions may be exacerbated by fluid overload or rapid changes in blood glucose levels. Close monitoring is required in such patients during administration.

Drug Interaction

The combination of Dextran and Dextrose may interact with anticoagulants, insulin, and other drugs that influence fluid and electrolyte balance. Dextrose can cause hyperglycemia, necessitating adjustments to antidiabetic medications.

Food Interactions

There are no significant food interactions with Dextran and Dextrose, as both are administered intravenously. However, patients receiving dextrose should avoid excessive carbohydrate intake during treatment to prevent hyperglycemia.

Pregnancy Use

Dextran and Dextrose can be used during pregnancy under medical supervision. However, caution should be exercised to avoid fluid overload and hyperglycemia, especially in women with preexisting diabetes or gestational diabetes.

Lactation Use

Dextran and Dextrose can be used during lactation with caution. Dextrose, being a naturally occurring sugar, poses minimal risk, but blood sugar levels should be monitored, especially in lactating women with diabetes.

Acute Overdose

An acute overdose of Dextran can result in hypervolemia, fluid overload, and potential pulmonary edema. Overdose of Dextrose can cause severe hyperglycemia, osmotic diuresis, and dehydration. Treatment involves stopping the infusion, administering diuretics if necessary, and correcting electrolyte and fluid imbalances.

Contraindication

The use of Dextran is contraindicated in patients with known hypersensitivity to Dextran, patients with severe dehydration without adequate electrolyte replacement, and in those with bleeding disorders or conditions that increase the risk of hemorrhage. Dextrose should be used cautiously in patients with diabetes or hyperosmolar conditions.

Use Direction

Dextran and Dextrose should be administered under strict medical supervision, with doses tailored to the patient's condition. Infusion rates should be adjusted based on the patient's clinical status, with regular monitoring of blood volume, glucose levels, and electrolytes.

Storage Conditions

Store Dextran and Dextrose solutions at room temperature, protected from light. Do not freeze. Ensure that the solution is clear and free from particulate matter before use. Discard any unused portions after opening.

Volume of Distribution

Dextran has a large volume of distribution in the extracellular space, where it exerts its plasma-expanding effects. Dextrose is widely distributed in body tissues after metabolism.

Half Life

The half-life of Dextran varies depending on the molecular weight, typically ranging from 6 to 12 hours. Dextrose has a much shorter half-life as it is rapidly metabolized for energy production.

Clearance

Dextran is cleared primarily through the kidneys, while Dextrose is metabolized by cells and cleared from the bloodstream as it is used for energy or stored as glycogen. Excess glucose is excreted by the kidneys in cases of hyperglycemia.